112 related articles for article (PubMed ID: 16296320)
1. [Regulation of the immune system by protein tyrosine phosphatases].
Mizuno K; Yakura H
Seikagaku; 2005 Oct; 77(10):1281-90. PubMed ID: 16296320
[No Abstract] [Full Text] [Related]
2. [Noonan syndrome and Leopard syndrome linked to mutation of the gene PTPN11].
Dereure O
Ann Dermatol Venereol; 2005 Apr; 132(4):400. PubMed ID: 15886577
[No Abstract] [Full Text] [Related]
3. Noonan syndrome with leukaemoid reaction and overproduction of catecholamines: a case report.
Kondoh T; Ishii E; Aoki Y; Shimizu T; Zaitsu M; Matsubara Y; Moriuchi H
Eur J Pediatr; 2003 Jul; 162(7-8):548-549. PubMed ID: 12739139
[No Abstract] [Full Text] [Related]
4. Noonan syndrome-associated SHP2/PTPN11 mutants cause EGF-dependent prolonged GAB1 binding and sustained ERK2/MAPK1 activation.
Fragale A; Tartaglia M; Wu J; Gelb BD
Hum Mutat; 2004 Mar; 23(3):267-77. PubMed ID: 14974085
[TBL] [Abstract][Full Text] [Related]
5. Novel mitochondrial DNA mutations implicated in Noonan syndrome.
Dhandapany PS; Sadayappan S; Vanniarajan A; Karthikeyan B; Nagaraj C; Gowrishankar K; Selvam GS; Singh L; Thangaraj K
Int J Cardiol; 2007 Aug; 120(2):284-5. PubMed ID: 17092585
[TBL] [Abstract][Full Text] [Related]
6. [Clinical symptoms and molecular pathogenesis of Noonan syndrome--current concepts].
Klapecki J; Obersztyn E; Laniewski-Wollk M; Szpecht-Potocka A; Mazurczak T
Med Wieku Rozwoj; 2006; 10(1 Pt 2):289-308. PubMed ID: 17028394
[TBL] [Abstract][Full Text] [Related]
7. CD45 regulates tyrosine phosphorylation of CD22 and its association with the protein tyrosine phosphatase SHP-1.
Greer SF; Justement LB
J Immunol; 1999 May; 162(9):5278-86. PubMed ID: 10228003
[TBL] [Abstract][Full Text] [Related]
8. The Src-homology domain 2-bearing protein tyrosine phosphatase-1 inhibits antigen receptor-induced apoptosis of activated peripheral T cells.
Zhang J; Somani AK; Watt S; Mills GB; Siminovitch KA
J Immunol; 1999 Jun; 162(11):6359-67. PubMed ID: 10352248
[TBL] [Abstract][Full Text] [Related]
9. Noonan syndrome type I with PTPN11 3 bp deletion: structure-function implications.
Lee WH; Raas-Rotschild A; Miteva MA; Bolasco G; Rein A; Gillis D; Vidaud D; Vidaud M; Villoutreix BO; Parfait B
Proteins; 2005 Jan; 58(1):7-13. PubMed ID: 15521065
[TBL] [Abstract][Full Text] [Related]
10. Altered regulation of SHP-2 and PTP 1B tyrosine phosphatases in cystic kidneys from bcl-2 -/- mice.
Sorenson CM; Sheibani N
Am J Physiol Renal Physiol; 2002 Mar; 282(3):F442-50. PubMed ID: 11832424
[TBL] [Abstract][Full Text] [Related]
11. Genetics and variation in phenotype in Noonan syndrome.
Jongmans M; Otten B; Noordam K; van der Burgt I
Horm Res; 2004; 62 Suppl 3():56-9. PubMed ID: 15539800
[TBL] [Abstract][Full Text] [Related]
12. SH2 domains: a question of independence.
Wandless TJ
Curr Biol; 1996 Feb; 6(2):125-7. PubMed ID: 8673454
[TBL] [Abstract][Full Text] [Related]
13. A novel PTPN11 gene mutation in a patient with LEOPARD Syndrome.
Du-Thanh A; Cave H; Bessis D; Puso C; Guilhou JJ; Dereure O
Arch Dermatol; 2007 Sep; 143(9):1210-1. PubMed ID: 17875892
[No Abstract] [Full Text] [Related]
14. Structure and function of SH2-domain containing tyrosine phosphatases.
Neel BG
Semin Cell Biol; 1993 Dec; 4(6):419-32. PubMed ID: 8305681
[TBL] [Abstract][Full Text] [Related]
15. The 'Shp'ing news: SH2 domain-containing tyrosine phosphatases in cell signaling.
Neel BG; Gu H; Pao L
Trends Biochem Sci; 2003 Jun; 28(6):284-93. PubMed ID: 12826400
[TBL] [Abstract][Full Text] [Related]
16. The tyrosine phosphatase SHP-2 is required for mediating phosphatidylinositol 3-kinase/Akt activation by growth factors.
Wu CJ; O'Rourke DM; Feng GS; Johnson GR; Wang Q; Greene MI
Oncogene; 2001 Sep; 20(42):6018-25. PubMed ID: 11593409
[TBL] [Abstract][Full Text] [Related]
17. PTPN11 mutations in Noonan syndrome type I: detection of recurrent mutations in exons 3 and 13.
Maheshwari M; Belmont J; Fernbach S; Ho T; Molinari L; Yakub I; Yu F; Combes A; Towbin J; Craigen WJ; Gibbs R
Hum Mutat; 2002 Oct; 20(4):298-304. PubMed ID: 12325025
[TBL] [Abstract][Full Text] [Related]
18. From form to function: signaling by protein tyrosine phosphatases.
Tonks NK; Neel BG
Cell; 1996 Nov; 87(3):365-8. PubMed ID: 8898190
[No Abstract] [Full Text] [Related]
19. [Disturbance of intracellular signaling by Helicobacter pylori infection].
Higashi H
Seikagaku; 2003 Sep; 75(9):1243-6. PubMed ID: 14577356
[No Abstract] [Full Text] [Related]
20. Tyrosine phosphatase SHP-2 dephosphorylates the platelet-derived growth factor receptor but enhances its downstream signalling.
Zhao R; Zhao ZJ
Biochem J; 1999 Feb; 338 ( Pt 1)(Pt 1):35-9. PubMed ID: 9931295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]